← SynDRA
GS 6201
SynDRA canonical compound SYN0008958 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ADORA1 | ADORA2A | ADORA2B | ADORA3 |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
All known targets
- ADORA2B
- ADORA1
- ADORA2A
- ADORA3
Mechanisms of action (all sources)
- ADORA2B ANTAGONIST
- Adenosine A2b receptor antagonist
- ADORA1 ANTAGONIST
- ADORA2A ANTAGONIST
- ADORA3 ANTAGONIST
- adenosine receptor antagonist
- ADORA2B MODULATOR
Cross-references
Synonyms
- GS-6201
- CVT-6883
- CVT 6883
- UNII-67CKV7X08G
- CHEMBL260933
- 67CKV7X08G
- 3-Ethyl-3,9-dihydro-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-1H-purine-2,6-dione
- 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-1H-purine-2,6(3H,7H)-dione
- Kinome_3621
- SCHEMBL238694
- GTPL5615
- CVT6883
- AOB4675
- MolPort-035-765-814
- CTV-6883
- ZINC29055563
- BDBM50236738
- AKOS024458311
- API0004749
- 3-ethyl-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]pyrazol-4-yl]-7H-purine-2,6-dione
- Cvt-6883
- RefChem:128980
- orb1308258
- SCHEMBL3394050
- SCHEMBL29504135
- SCHEMBL29504136
- SCHEMBL29504137
- SCHEMBL29504138
- KOYXXLLNCXWUNF-UHFFFAOYSA-N
- GLXC-03506
- AKOS037643538
- FC34579
- NCGC00345800-01
- NCGC00345800-02
- NCGC00345800-05
- AS-16811
- DA-73881
- HY-10081
- CS-0002439
Look up GS 6201 in the interactive SynDRA portal →